Vanguard Group Inc Aim Immuno Tech Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,988,704 shares of AIM stock, worth $238,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,988,704
Previous 1,988,704
-0.0%
Holding current value
$238,644
Previous $536,000
25.93%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AIM
# of Institutions
38Shares Held
4.65MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY698KShares$83,7920.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$55,6810.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il359KShares$43,0780.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$31,2570.0% of portfolio
-
State Street Corp Boston, MA173KShares$20,7720.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $5.77M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...